SHELTON CAPITAL MANAGEMENT - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.

Quarter-by-quarter ownership
SHELTON CAPITAL MANAGEMENT ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2023$8,339
-68.9%
11,8640.0%0.00%
-100.0%
Q4 2022$26,813
-29.4%
11,8640.0%0.00%
+50.0%
Q3 2022$38,000
-15.6%
11,8640.0%0.00%0.0%
Q2 2022$45,000
-29.7%
11,8640.0%0.00%0.0%
Q1 2022$64,000
-53.6%
11,864
+15.7%
0.00%
-60.0%
Q4 2021$138,000
-25.0%
10,2500.0%0.01%
-28.6%
Q3 2021$184,000
+4.5%
10,2500.0%0.01%0.0%
Q2 2021$176,000
-14.1%
10,2500.0%0.01%0.0%
Q1 2021$205,000
+17.8%
10,2500.0%0.01%
-12.5%
Q4 2020$174,000
+2.4%
10,2500.0%0.01%
+14.3%
Q3 2020$170,000
-28.3%
10,2500.0%0.01%
-46.2%
Q2 2020$237,000
+23.4%
10,250
-4.5%
0.01%
-7.1%
Q1 2020$192,000
-23.2%
10,730
-7.4%
0.01%0.0%
Q4 2019$250,000
-70.0%
11,587
-17.0%
0.01%
-73.6%
Q4 2017$833,000
+148.7%
13,9520.0%0.05%
+130.4%
Q3 2017$335,000
+12.0%
13,952
-8.7%
0.02%
+9.5%
Q2 2017$299,000
-6.3%
15,283
+12.5%
0.02%
-4.5%
Q1 2017$319,000
+132.8%
13,587
+21.4%
0.02%
+120.0%
Q4 2016$137,000
-28.6%
11,1950.0%0.01%
-37.5%
Q3 2016$192,000
+20.8%
11,1950.0%0.02%
+14.3%
Q2 2016$159,000
+3.2%
11,1950.0%0.01%0.0%
Q1 2016$154,000
-9.9%
11,195
+10.2%
0.01%
-17.6%
Q4 2015$171,000
+54.1%
10,1600.0%0.02%
+41.7%
Q3 2015$111,00010,1600.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2018
NameSharesValueWeighting ↓
TIRSCHWELL & LOEWY INC 588,908$7,138,0001.23%
Granahan Investment Management 3,693,956$44,771,0001.21%
NEA Management Company, LLC 1,825,600$22,126,0001.09%
FIC CAPITAL INC 150,868$1,829,0000.75%
Rhenman & Partners Asset Management AB 181,797$2,203,0000.66%
SOPHROSYNE CAPITAL LLC 60,200$728,0000.64%
HARVEY CAPITAL MANAGEMENT INC 130,400$1,580,0000.63%
Artal Group S.A. 1,300,000$15,756,0000.57%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 564,418$6,840,0000.47%
OppenheimerFunds, Inc. 24,400,000$295,728,0000.35%
View complete list of NEKTAR THERAPEUTICS shareholders